MMP9 is an independent risk factor for coronary artery disease in KD (Korematsu et al., 2012), and the MMP-9 mRNA level was increased in KD patients with coronary artery disease and decreased at least 3 weeks after IVIG treatment (Kuo et al., 2017). Here, MMP9 is linked to coronary artery disorder.